Darnitsa

Darnitsa is a pharmaceutical company in Ukraine.

According to estimates, Darnitsa occupies 7% of the Ukrainian pharmaceutical market.

The company produces over 250 names of finished pharmaceutical products. The company's facilities are located on about 30 thousand square meters of production facilities.

In 2016, Darnitsa entered the Top 20 most innovative companies in Ukraine by Forbes Ukraine.

As of the end of 2017, the company is one of the ten largest pharmaceutical manufacturers in Ukraine and one of the ten largest hospital suppliers.

In 2018, "Darnitsa" entered the top five of the rating "The Most Expensive Brands of Ukraine" according to the magazine "Correspondent".

In 2018, Darnitsa increased its net profit by 31% compared to 2017 - up to UAH 449.13 million. Net income from product sales for the year increased by 18.7% to UAH 3 billion.

In 2019, Darnitsa's net profit increased by 30%. Net income from product sales, compared to 2018, increased by 10.3% - to UAH 3.312 billion. Income tax of "Darnitsa" for 2019 amounted to UAH 120.6 million.